These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22183577)

  • 1. The future of molecular dynamics simulations in drug discovery.
    Borhani DW; Shaw DE
    J Comput Aided Mol Des; 2012 Jan; 26(1):15-26. PubMed ID: 22183577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-based lead discovery: challenges and opportunities.
    Sun C; Petros AM; Hajduk PJ
    J Comput Aided Mol Des; 2011 Jul; 25(7):607-10. PubMed ID: 21732249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
    Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
    Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
    Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
    Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations.
    Cournia Z; Allen B; Sherman W
    J Chem Inf Model; 2017 Dec; 57(12):2911-2937. PubMed ID: 29243483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational chemistry in 25 years.
    Abagyan R
    J Comput Aided Mol Des; 2012 Jan; 26(1):9-10. PubMed ID: 22160588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The errors of our ways: taking account of error in computer-aided drug design to build confidence intervals for our next 25 years.
    Stouch TR
    J Comput Aided Mol Des; 2012 Jan; 26(1):125-34. PubMed ID: 22246296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics-driven drug discovery: leaping forward with confidence.
    Ganesan A; Coote ML; Barakat K
    Drug Discov Today; 2017 Feb; 22(2):249-269. PubMed ID: 27890821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solvents to Fragments to Drugs: MD Applications in Drug Design.
    Defelipe LA; Arcon JP; Modenutti CP; Marti MA; Turjanski AG; Barril X
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs.
    Platania CBM; Bucolo C
    Methods Mol Biol; 2021; 2253():245-254. PubMed ID: 33315227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The slow but steady rise of binding free energy calculations in drug discovery.
    Xu H
    J Comput Aided Mol Des; 2023 Feb; 37(2):67-74. PubMed ID: 36469232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of biomolecular simulation in the pharmaceutical industry: what we can learn from aerodynamics modelling and weather prediction. Part 1. understanding the physical and computational complexity of in silico drug design.
    Edwards T; Foloppe N; Harris SA; Wells G
    Acta Crystallogr D Struct Biol; 2021 Nov; 77(Pt 11):1348-1356. PubMed ID: 34726163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Discovery and Molecular Dynamics: Methods, Applications and Perspective Beyond the Second Timescale.
    Martínez-Rosell G; Giorgino T; Harvey MJ; de Fabritiis G
    Curr Top Med Chem; 2017; 17(23):2617-2625. PubMed ID: 28413955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ensemble Docking in Drug Discovery: How Many Protein Configurations from Molecular Dynamics Simulations are Needed To Reproduce Known Ligand Binding?
    Evangelista Falcon W; Ellingson SR; Smith JC; Baudry J
    J Phys Chem B; 2019 Jun; 123(25):5189-5195. PubMed ID: 30695645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from the Fersht laboratory could be vital for the future of the pharmaceutical industry.
    Ward WH
    Protein Eng Des Sel; 2011 Jan; 24(1-2):65-7. PubMed ID: 20876191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of protein dynamics and their relevance to drug discovery.
    Salsbury FR
    Curr Opin Pharmacol; 2010 Dec; 10(6):738-44. PubMed ID: 20971684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation model-based drug discovery and development: quantitative and systems pharmacology.
    Allerheiligen SR
    Clin Pharmacol Ther; 2010 Jul; 88(1):135-7. PubMed ID: 20531467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Molecular Dynamics Simulations in Structure-Based Drug Discovery.
    Bera I; Payghan PV
    Curr Pharm Des; 2019; 25(31):3339-3349. PubMed ID: 31480998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations and novel drug discovery.
    Liu X; Shi D; Zhou S; Liu H; Liu H; Yao X
    Expert Opin Drug Discov; 2018 Jan; 13(1):23-37. PubMed ID: 29139324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15 Years of molecular simulation of drug-binding kinetics.
    Wong CF
    Expert Opin Drug Discov; 2023; 18(12):1333-1348. PubMed ID: 37789731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.